A shining light for the biotechnology industry, for Kendall Square, and for patients with rare diseases has passed away. Henri Termeer founded and led Genzyme for close to 30 years, greatly influencing the rise of biotech and bringing a patient-centric approach to the business.
The funding, led by former Genzyme CEO Henri Termeer, funds the development of an immunomodulator that could be used for multiple sclerosis, type 1 diabetes, psoriasis and other autoimmune disease.
Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform.